BridgeMD
New treatment option for Headache, Cluster
Official title SPG Pulsed Radiofrequency for Chronic Cluster Headache
ClinicalTrials.gov ID: NCT06787677
What this study is testing
- What it's testing
- Cluster headache (CH) is a devastating disorder characterized by ipsilateral headache and associated trigeminal autonomic symptoms, with a yearly prevalence of 0.1%. There is a huge clinically unmet demand for an effective therapeutic method for CH.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Chronic cluster headache;
- At least four attacks per week;
- Minimum age of 18 years;
- Non-response to verapamil and lithium treatment in the past, intolerance, or contraindication to verapamil and lithium, along with non-response...
You likely can't join if
- Pregnancy or breastfeeding;
- Presence of cardiac pacemaker or other neuromodulatory devices;
- Pyschiatric and cognitive disorders;
- Serious drug habituation or overuse of acute-headache medication;
- History of stroke or intracranial aneurysm, or at risk for serious or acute cardiovascular events;
- Infection at the puncture site;
See the full eligibility criteria
- Chronic cluster headache;
- At least four attacks per week;
- Minimum age of 18 years;
- Non-response to verapamil and lithium treatment in the past, intolerance, or contraindication to verapamil and lithium, along with non-response, intolerance, or contraindica-tion to topiramate, or gabapentin.
- Pregnancy or breastfeeding;
- Presence of cardiac pacemaker or other neuromodulatory devices;
- Pyschiatric and cognitive disorders;
- Serious drug habituation or overuse of acute-headache medication;
- History of stroke or intracranial aneurysm, or at risk for serious or acute cardiovascular events;
- Infection at the puncture site;
- Previous history of invasive treatments such as sphenopalatine ganglion radiofrequency thermocoagulation and chemical destruction.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.